Dr. Tishler is a Cannabinoid Specialist, a term that he coined many years ago, as he sought to increase the standard of care for patients and the level of education of his colleagues based on data and best practices. He is the Founder and President of the Association of Cannabinoid Specialists which aims to educate clinicians, lawmakers, and the industry about best practices and needed tools for proper patient care.
Dr. Tishler graduated from both Harvard College and Harvard Medical School, trained in Internal Medicine at the Brigham and Women’s Hospital, and is faculty at both the Mass General Brigham and Harvard Medical School. He has spent many years as an Emergency Physician providing care to the underserved in East Boston and at the Veteran’s Administration. Having treated countless patients harmed by alcohol and drugs, his observation that he had never seen a cannabis overdose led Dr. Tishler to delve deeply into the science of cannabinoids’ safety and treatment.
Dr. Tishler is a national/international Keynote speaker and author on a variety of topics related to the medical applications of cannabinoids, including cannabinoid dosing paradigms, use of cannabinoids for pain management and opioid sparing, cannabinoids for behavioral health, and approaches to treatment of human sexual dysfunction using cannabinoids. He has numerous scientific and lay publications, has developed ongoing CME educational programs through both Association of Cannabinoid Specialists, Harvard Medical School, and other outlets. He maintains a steady roster of Ph.D. candidates and resident-trainees in his clinic, InhaleMD.
Dr. Tishler is a strong proponent of industry, and has been an advisor to several companies looking to improve the safety and efficacy of delivery of cannabinoid medicines. However, he strongly believes that the current approach to cannabinoid medical care, and legalization policy in general, is not in patients’ best interests and leaves patients at the mercy of an under-regulated industry. He and the ACS strive to improve these conditions.
He is recipient of Clinician of the Year awards from Americans for Safe Access and the Marfan’s Society. He is advisor to Massachusetts Cannabis Control Commission, Massachusetts, Georgia, and Alabama Medical Societies, and board member of Council for Federal Cannabis Regulation, Massachusetts Patient Advocacy Alliance, and was awarded lifetime membership on the Hadassah Physician’s Council for his work in cannabinoid medicine.
- Massachusetts Medical Society
- Brigham and Women’s Hospital HIV conference
- Beth Israel Deaconess Hospital Social Work Grand Rounds
- Brigham and Women’s Hospital Grand Rounds
- Wicked Good Weed Conference
- Massachusetts Patient Advocacy Alliance Conference
- Massachusetts General Hospital Primary Care group
- Patients Out of Time national conference 2016
- Brookline Patient Symposium
- New England Cannabis Convention
- Green Flower Media Health Summit
- Tufts Medical Center
- Massachusetts Biotechnology Council
- Portland Weed Week
- Regis College
- Boston VA Healthcare System
- New England Treatment Access
- Chronic back pain
- Rheumatoid Arthritis